0001592102-22-000001.txt : 20221219 0001592102-22-000001.hdr.sgml : 20221219 20221216175910 ACCESSION NUMBER: 0001592102-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221219 DATE AS OF CHANGE: 20221216 EFFECTIVENESS DATE: 20221219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ActX, Inc. CENTRAL INDEX KEY: 0001592102 IRS NUMBER: 461268976 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-467827 FILM NUMBER: 221469146 BUSINESS ADDRESS: STREET 1: 1100 DEXTER AVENUE NORTH STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-274-1506 MAIL ADDRESS: STREET 1: 1100 DEXTER AVENUE NORTH STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001592102 ActX, Inc. 2101 4th Avenue SUITE 1180 SEATTLE WA WASHINGTON 98121 2066732245 DELAWARE None None Corporation true Andrew Ury 2101 4th Avenue Suite 1180 Seattle WA WASHINGTON 98121 Executive Officer Director Eric Michelman 2101 4th Avenue Suite 1180 Seattle WA WASHINGTON 98121 Director Sarah Corley 2101 4th Avenue Suite 1180 Seattle WA WASHINGTON 98121 Director Other Health Care Decline to Disclose 06b false 2022-12-03 false true true Preferred Stock Financing and conversion of convertible notes false 10000 6100000 5993148 106852 The total amount sold includes the conversion of convertible notes with an aggregate amount $4,207,742.70. false 43 0 0 0 false ActX, Inc. Andrew Ury Andrew Ury CEO 2022-12-16